Management ChangeJul 15, 2026, 08:15 AM
Biogen Appoints Michael J. Parini as Chief Legal Officer
AI Summary
Biogen Inc. has announced the appointment of Michael J. Parini as its new Chief Legal Officer, effective August 3, 2026. Mr. Parini will join Biogen's Executive Committee and report directly to CEO Christopher A. Viehbacher, overseeing the company's global legal and compliance functions. He brings over two decades of extensive legal and strategic leadership experience from the biopharmaceutical industry, including prior roles as CEO of Spur Therapeutics and various leadership positions at Vertex Pharmaceuticals and Pfizer. This appointment is expected to contribute to Biogen's renewed growth strategy.
Key Highlights
- Michael J. Parini appointed Chief Legal Officer of Biogen, effective August 3, 2026.
- Parini will serve as a member of Biogen's Executive Committee and report to CEO Christopher A. Viehbacher.
- He will oversee Biogen’s global legal and compliance functions.
- Parini brings over 20 years of senior legal and strategic leadership experience in the biopharmaceutical industry.
- He previously served as CEO of Spur Therapeutics, advancing a rare disease program into Phase 3 development.
- Prior to Spur Therapeutics, he held leadership roles at Vertex Pharmaceuticals, including Chief Administrative, Legal and Business Development Officer.
- At Vertex, he helped lead acquisitions and negotiate market access agreements for cystic fibrosis medicines.
- He also held multiple senior legal roles at Pfizer, including Chief Litigation Counsel.
Price Impact
More from BIIB